Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults

被引:13
|
作者
Garcia, David O. [1 ]
Morrill, Kristin E. [2 ]
Lopez-Pentecost, Melissa [3 ]
Villavicencio, Edgar A. [1 ]
Vogel, Rosa M. [1 ]
Bell, Melanie L. [4 ]
Klimentidis, Yann C. [4 ]
Marrero, David G. [1 ]
Thomson, Cynthia A. [1 ]
机构
[1] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, Tucson, AZ 85714 USA
[2] Univ Arizona, Canc Ctr, Tucson, AZ 85714 USA
[3] Univ Arizona, Coll Med, Clin Translat Sci, Tucson, AZ 85714 USA
[4] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, Tucson, AZ 85714 USA
关键词
UNITED-STATES; AMERICAN ASSOCIATION; DIAGNOSIS; PREVALENCE; MANAGEMENT; PNPLA3; STEATOSIS; FIBROSIS; DIFFERS; NAFLD;
D O I
10.1002/hep4.1896
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of nonalcoholic fatty liver disease (NAFLD) is highest among Mexican-origin (MO) adults. Few studies have estimated the prevalence of NAFLD in this subpopulation, particularly by sex and age. We assessed the prevalence of NAFLD in a community sample of MO adults residing in a border region of southern Arizona and determined risk factors associated with NAFLD. A total of 307 MO adults (n = 194 women; n = 113 men) with overweight or obesity completed an in-person study visit, including vibration-controlled transient elastography (FibroScan) for the assessment of NAFLD status. A continuous attenuation parameter score of >= 288 dB/m (>= 5% hepatic steatosis) indicated NAFLD status. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for NAFLD. We identified 155 participants (50%) with NAFLD, including 52% of women and 48% of men; there were no sex differences in steatosis (men, 287.8 dB/m; women, 288.4 dB/m). Sex, age, patatin-like phospholipase domain containing 3 (PNPLA3) risk allele carrier status, comorbidities, and cultural and behavioral variables were not associated with NAFLD status. There was some evidence for effect modification of body mass index (BMI) by sex (P-interaction = 0.08). The estimated OR for an increase in BMI of 5 kg/m(2) was 3.36 (95% CI, 1.90, 5.91) for men and 1.92 (95% CI, 1.40, 2.64) for women. In post hoc analyses treating steatosis as a continuous variable in a linear regression, significant effect modification was found for BMI by sex (P-interaction = 0.03), age (P = 0.05), and PNPLA3 risk allele carrier status (P = 0.02). Conclusion: Lifestyle interventions to reduce body weight, with consideration of age and genetic risk status, are needed to stem the higher rates of NAFLD observed for MO populations.
引用
收藏
页码:1322 / 1335
页数:14
相关论文
共 50 条
  • [1] Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study
    Morrill, Kristin E.
    Crocker, Rebecca M.
    Hingle, Melanie D.
    Thomson, Cynthia A.
    Garcia, David O.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [2] A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease
    Chen, Li-Wei
    Huang, Pin-Ren
    Chien, Cheng-Hung
    Lin, Chih-Lang
    Chien, Rong-Nan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 173 - 181
  • [3] Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
    Pozzan, Roselee
    Pena, Ronaldo Gama
    Vergara Palma, Catia Cristina Silva Sousa
    Abi-Abib, Raquel De Carvalho
    Terra, Carlos
    Cobas, Roberta Arnoldi
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (04): : 452 - 458
  • [4] Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals
    Piao, Cindy
    Arteaga, Elvis J.
    Chen, Shuai
    Guo, Aili
    Macdonald, Scott T.
    Sarkar, Souvik
    METABOLIC SYNDROME AND RELATED DISORDERS, 2023, 21 (09) : 475 - 478
  • [5] Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
    Huh, Youn
    Cho, Yoon Jeong
    Nam, Ga Eun
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2022, 31 (01) : 17 - 27
  • [6] Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
    Adams, Leon A.
    Harmsen, Scott
    St Sauver, Jennifer L.
    Charatcharoenwitthaya, Phunchai
    Enders, Felicity B.
    Therneau, Terry
    Angulo, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) : 1567 - 1573
  • [7] Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease
    Behari, Jaideep
    Bradley, Allison
    Townsend, Kevin
    Becich, Michael J.
    Cappella, Nickie
    Chuang, Cynthia H.
    Fernandez, Soledad A.
    Ford, Daniel E.
    Kirchner, H. Lester
    Morgan, Richard
    Paranjape, Anuradha
    Silverstein, Jonathan C.
    Williams, David A.
    Donahoo, W. Troy
    Asrani, Sumeet K.
    Ntanios, Fady
    Ateya, Mohammad
    Hegeman-Dingle, Rozelle
    McLeod, Euan
    McTigue, Kathleen
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (02) : 370 - 383
  • [8] Risk factors for fatty liver disease associated with metabolic dysfunction in the Hispanic-Mexican population
    Morales-Romero, Jaime
    Cristina Ortiz-Leon, Maria
    Hernandez-Gutierrez, Hector
    Bahena-Ceron, Roberto A.
    Miranda-Reza, Aide
    Marin-Carmona, Jose A.
    Rodriguez-Romero, Edit
    Mora, Silvia I.
    Garcia-Roman, Jonathan
    Perez-Carreon, Julio I.
    Rivadeneyra-Dominguez, Eduardo
    Riande-Juarez, Gabriel
    Garcia-Roman, Rebeca
    REVISTA ESPANOLA DE SALUD PUBLICA, 2023, 97 : E1 - E15
  • [9] Risk factors in nonalcoholic fatty liver disease
    Ko, Eunji
    Yoon, Eileen L.
    Jun, Dae Won
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S79 - S85
  • [10] Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study
    Song, Qi-Rui
    Liu, Shuo-Lin
    Ling, Qian-Hui
    Gao, Qian-Nan
    Yang, Rui-Xue
    Chen, Shuo-Hua
    Wu, Shou-Ling
    Chen, Mu-Lei
    Cai, Jun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13